This is a condition where the body doesn't make enough of certain types of antibodies, which are proteins that help fight infections. It can make people more susceptible to infections, especially bacterial ones. It's a type of immune system problem.
Every report comes from a Lived member, sent anonymously.
Have you tried IVIG for Dysgammaglobulinemia?
Dysgammaglobulinemia is an umbrella term for immune conditions in which the body makes too little of one or more types of antibody while still making the others normally. Antibodies, also called immunoglobulins, are proteins that recognize germs and help clear them. They come in several classes with different jobs: IgG and IgM mainly protect the blood and body tissues, while IgA guards the moist linings of the airways, gut and urinary and genital tracts. When one class is missing or low, the gap tends to show up as infections in the places that class usually defends. The conditions under this label differ a great deal in severity. The most common is selective IgA deficiency, which affects roughly 1 in 500 people in North America. Many people with it have no symptoms and find out only when a blood test is done for another reason, such as checking for celiac disease. IgG subclass deficiency and selective IgM deficiency are also usually mild. At the other end, hyper-IgM syndromes are rare inherited conditions that begin in the first year or two of life: the immune system can make IgM but cannot switch to making IgG, IgA or IgE, which leaves a child open to serious infections. Dysgammaglobulinemia is different from conditions in which nearly all antibody production fails, such as common variable immune deficiency (CVID), although some people first diagnosed with a selective deficiency are later found to have CVID.
Most selective antibody deficiencies are primary, meaning they come from how a person's own immune system developed rather than from anything they did or were exposed to. Selective IgA deficiency runs in families in about 1 in 5 cases and sometimes appears in the same families as CVID, but its genetic basis is not well defined. IgG subclass deficiency has no clear inheritance pattern either. Hyper-IgM syndromes are different because they are caused by known gene changes. The most common form is X-linked, passed down by mothers who carry the change and affecting mainly boys; other forms occur when a child inherits a changed gene from both parents. Low antibody levels can also be secondary to something else. Before a low IgM level is treated as a primary condition, for example, clinicians look for causes such as leukemia, lymphoma or medicines that suppress the immune system. Age matters too: in young children some IgG subclasses are naturally low and do not reach adult levels until about age 10, so a low result can reflect an immune system that is still maturing. Allergies and autoimmune conditions, in which the immune system attacks the body's own tissues, are more common in people with these deficiencies. They are linked conditions rather than causes.
Testing usually starts because of ear, sinus or chest infections that keep coming back, ongoing diarrhea, or an unexpected result found during other testing. The first step is a blood test that measures the main antibody classes: IgG, IgA and IgM. Dysgammaglobulinemia is a pattern in those results, with one or more classes low while the others are normal. Each subtype has its own definition. Selective IgA deficiency is diagnosed when IgA is undetectable (usually reported as below 7 mg/dL) while IgG and IgM are normal, in someone at least 4 years old. Because antibody levels change with age, results are compared with normal ranges for the person's age, and an abnormal result is usually repeated. A low IgG subclass level, for instance, should be confirmed at least a month later, partly because normal ranges are set so that about 2.5% of healthy people fall below them. A low number on its own does not show that the immune system is failing. Clinicians often check how well the body makes antibodies after vaccines, such as the pneumococcal vaccine, which targets a bacterium that commonly causes ear, sinus and lung infections. A low IgG subclass level matters mainly when infections recur and vaccine responses are poor. When a hyper-IgM syndrome is suspected, specialized tests of immune cells and genetic testing confirm the specific form. IgA deficiency can also affect other tests. The most commonly used celiac disease blood test looks for an antibody of the IgA type, so people with low IgA are often checked with a different type of celiac antibody test.
No product can replace missing IgA or IgM, so for the milder selective deficiencies, treatment focuses on preventing and treating the problems the gap causes. Infections are treated with antibiotics, ideally chosen for the specific germ. Some people with persistent sinus or bronchial infections take a preventive antibiotic long term; the benefits and risks of this are worth discussing, and it is generally not recommended for selective IgM deficiency. In IgG subclass deficiency, extra pneumococcal vaccination may be used to strengthen protection. Allergies and autoimmune conditions linked to these deficiencies are treated much as they would be in anyone else. Immunoglobulin replacement therapy is a blood product that supplies IgG antibodies, given either through a vein (intravenous immunoglobulin, IVIG) or under the skin (subcutaneous immunoglobulin, SCIG). It is not routine for mild deficiencies. In IgG subclass deficiency, a trial of about six months may be considered when infections keep recurring and affect quality of life despite antibiotics and vaccine responses are poor. It is also used for some people with IgA or IgM deficiency who have recurrent serious infections and poor vaccine responses. Low levels without frequent infections are not a reason for long-term treatment. Selective IgA deficiency carries one specific precaution. Some people with it make antibodies against IgA, which can, very rarely, cause a severe allergic reaction to blood products that contain IgA, including some immunoglobulin products. People with IgA deficiency who need a transfusion should receive washed red blood cells, which have the IgA-containing plasma removed, and the subcutaneous form is preferred if immunoglobulin replacement is needed. Hyper-IgM syndromes need more intensive care. Everyone with these conditions needs immunoglobulin replacement. In the X-linked form and a closely related inherited form, which also weaken other parts of the immune system, people take a preventive antibiotic, usually trimethoprim-sulfamethoxazole, against Pneumocystis pneumonia (a fungal lung infection that mainly affects people with weakened immunity), avoid live vaccines, and use bottled water when relying on well water or traveling outside the US to avoid Cryptosporidium, a parasite that can damage the gut and liver. A stem cell (bone marrow) transplant has successfully treated the X-linked form, and earlier transplant is associated with better survival, though long-term results are still being studied.
The outlook depends mostly on which antibody is affected. Selective IgA deficiency is usually one of the milder immune deficiencies, and the long-term outlook is generally very good. About half of people with it have problems with infections, while many have no symptoms at all. A smaller group develops allergies or autoimmune conditions such as celiac disease, rheumatoid arthritis or lupus, and a few have more severe disease. Selective IgM deficiency is also mild in most reported cases, though rare serious infections such as meningitis and sepsis (a body-wide reaction to infection) have been described. Children with low IgG subclasses often outgrow them, especially when the deficiency is found before age 5, and many go on to respond normally to vaccines. In others it persists into adulthood, and in some people a selective deficiency later turns out to be part of a broader immunodeficiency such as CVID. Because no test predicts who will improve, regular rechecks of antibody levels and vaccine responses are part of long-term care; people with selective IgM deficiency, for example, are usually seen every six months to a year. Normal school, work and daily routines are encouraged. Hyper-IgM syndromes are a different experience, with ongoing specialist care, regular immunoglobulin treatment and close attention to infections, but severity depends on the form. Forms that affect only the switch to other antibody types are usually well controlled with immunoglobulin replacement, and people with them can live long, productive lives. The X-linked form and the closely related inherited form (CD40 deficiency) also weaken other parts of the immune system, so they add preventive medicines, and even with immunoglobulin they leave some risk of unusual infections and of liver problems and some cancers over time. Before transplant and modern care, few people with these two forms lived beyond their 30s or 40s, and how people fare decades after transplant is not yet known.
Ask about an immune evaluation if you or your child has ear, sinus or chest infections that keep coming back or need repeated courses of antibiotics, especially alongside ongoing diarrhea, or if a blood test has shown a low antibody level. If you already have a diagnosis, tell your care team about new or unusual symptoms, especially fever, a cough that brings up mucus, a skin rash or sore joints, since starting treatment when it is needed makes a real difference. Hyper-IgM syndromes, especially the X-linked and CD40 forms, call for faster action because serious lung and gut infections are more likely. For someone with one of these forms, or another immune deficiency the care team has called severe, contact the team the same day for a fever, fast or difficult breathing, or diarrhea that does not settle. Before any transfusion or immunoglobulin treatment, make sure the clinicians know you have IgA deficiency.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Dysgammaglobulinemia is like, what's helped you, or ask the community a question.